Compare GRFS & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | RDNT |
|---|---|---|
| Founded | 1940 | 1985 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.6B |
| IPO Year | N/A | 1996 |
| Metric | GRFS | RDNT |
|---|---|---|
| Price | $7.13 | $68.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $10.15 | ★ $82.80 |
| AVG Volume (30 Days) | 657.9K | ★ 947.9K |
| Earning Date | 07-28-2022 | 05-11-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,616,630,000.00 |
| Revenue This Year | $4.49 | $22.78 |
| Revenue Next Year | $6.42 | $10.70 |
| P/E Ratio | $18.67 | ★ N/A |
| Revenue Growth | N/A | ★ 13.05 |
| 52 Week Low | $6.96 | $50.79 |
| 52 Week High | $11.14 | $85.84 |
| Indicator | GRFS | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 38.73 | 74.35 |
| Support Level | N/A | $64.71 |
| Resistance Level | $7.73 | $74.55 |
| Average True Range (ATR) | 0.16 | 3.22 |
| MACD | -0.01 | 1.26 |
| Stochastic Oscillator | 25.97 | 93.48 |
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.